Bio Pharma Dive
JULY 17, 2023
For $500 million, Novartis will acquire DTx Pharma and its preclinical neurological disease drugs, marking the Swiss company’s latest investment in gene-silencing medicines.
Pharmaceutical Technology
JULY 17, 2023
The recent reintroduction of the Pasteur Act seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription contract at a time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JULY 17, 2023
An organization of retinal specialists flagged six cases of severe eye inflammation from commercial use of Syfovre. Apellis says the drug’s safety profile is consistent with testing.
Pharmaceutical Technology
JULY 17, 2023
The move follows a positive decision made by the EMA earlier this year, broadening the use of Veklury to the high-risk patient group.
Bio Pharma Dive
JULY 17, 2023
Leaders from the firm said that, despite a turbulent biotech market, most of their existing limited partners returned to participate in the new fund, which will support approximately a dozen startups.
Pharmaceutical Technology
JULY 17, 2023
The US Federal Court overturned a previous ruling in the patent infringement case against Rockefeller University.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 17, 2023
On July 13, 2023, the U.S. Food and Drug Administration approved a drugmaker’s application for the first daily over-the-counter birth control pill for people seeking to prevent pregnancy.
Bio Pharma Dive
JULY 17, 2023
Developers AstraZeneca and Sanofi expect to make the preventive antibody treatment, called Beyfortus, available ahead of the upcoming cold season.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 17, 2023
Adverse drug reactions (ADRs) reporting with the help of digital technologies will give us the opportunity to evaluate our capability to detect signals of adverse events.
Bio Pharma Dive
JULY 17, 2023
Meet the pharma marketer of the future, primed for personalization and powered by technology.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Rethinking Clinical Trials
JULY 17, 2023
From left: Dr. Stephanie Ibemere and Dr. Kaitlyn McLeod The NIH Pragmatic Trials Collaboratory is welcoming its first class of fellows in a new program for early-career investigators from underrepresented or minoritized groups with a scholarly interest in pragmatic clinical trials. “We are very excited to welcome the 2 inaugural fellows to the NIH Pragmatic Trials Collaboratory Fellowship Program and give them the education and tools that they need to launch their careers as pragmatic clin
Bio Pharma Dive
JULY 17, 2023
The results come about two years after negative findings from an earlier phase of the study, and position the company to seek an approval in transthyretin amyloidosis cardiomyopathy.
Pharmaceutical Technology
JULY 17, 2023
The complete data readouts of two-Phase II trials are expected in 2024, with an additional open-label extension study currently in the works.
Bio Pharma Dive
JULY 17, 2023
New data presented Monday at a research conference support the case for Lilly’s donanemab, which works in a similar way as the two Alzheimer’s medicines recently approved in the U.S.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JULY 17, 2023
The Centre for Advanced Imaging (CAI) of the University of Queensland in Australia has unveiled a facility to develop therapies for cancer.
Bio Pharma Dive
JULY 17, 2023
With this highly marketable dosage form, scientists can effectively formulate poorly soluble drugs and supplements, while reducing development time and costs.
Pharmaceutical Technology
JULY 17, 2023
Antengene has received approval in Hong Kong for a new drug application (NDA) for Xpovio (selinexor) to treat multiple myeloma (R/R MM).
Outsourcing Pharma
JULY 17, 2023
The U.S. startup Readout AI has closed a pre-seed financing round to fuel the development of an artificial intelligence (AI)-based tool to speed up data analysis in clinical trials.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
JULY 17, 2023
Eli Lilly and Company has signed an agreement for the acquisition of biopharmaceutical firm Versanis Bio in a deal totalling $1.925bn.
Outsourcing Pharma
JULY 17, 2023
Cumulus Neuroscience, a global digital health company focused on advancing neuroscience clinical trials and patient care, presented interim data from their first-in-class CNS-102 feasibility study at the European Network to Cure ALS Annual Meeting (ENCALS) in Barcelona, Spain.
Pharmaceutical Technology
JULY 17, 2023
The companies will develop new molecules using Eleven's innovative DELiveri platform to treat cardiometabolic diseases.
Pharma Marketing Network
JULY 17, 2023
Amy Turnquist has more than 20 years of experience leading teams to create and deliver innovative, client-centric solutions that connect pharmaceutical brands with their HCP and consumer audiences. In her role as a Principal at North Highland, Amy helps healthcare organizations transform their engagement strategy, driving sustainable change and measurable impact by keeping people at the heart of every decision.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
JULY 17, 2023
UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC erectile dysfunction gel, Eroxon, in the US.
Drug Patent Watch
JULY 17, 2023
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents… The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceutical Technology
JULY 17, 2023
In the pharmaceutical sector, general and operational manager roles are the most in demand, according to Jobs data.
BioPharma Reporter
JULY 17, 2023
Japanâs Ministry of Health, Labour, and Welfare approved FluMist Quadrivalent in March 2023, marking the first approval of an intranasal vaccine in the countryâs history.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
JULY 17, 2023
Korro Bio has signed a definitive merger agreement with Frequency Therapeutics to create a genetic medicines firm.
XTalks
JULY 17, 2023
Boston Scientific’s Vercise Neural Navigator 5 Software for deep brain stimulation (DBS) has been granted approval by the US Food and Drug Administration (FDA). The Vercise Neural Navigator software is used to program Boston Scientific’s Vercise DBS devices for the treatment of Parkinson’s disease and essential tremor. The fifth iteration of the software is designed to be specifically used with the company’s Vercise Genus devices.
Fierce Pharma
JULY 17, 2023
Sanofi’s immunization scheme is starting to fall into place thanks to an approval that could propel it and its partner AstraZeneca to the front lines of the respiratory syncytial virus (RSV) scene. | Sanofi’s immunization scheme is starting to fall into place thanks to an approval that could propel it and its partner AstraZeneca to the front lines of the RSV scene.
XTalks
JULY 17, 2023
Gastric cancer, which originates in the stomach, ranks among the most common cancers globally. Symptoms for early-stage gastric cancer often overlap with those of more mundane stomach-related ailments, leading to late-stage or metastatic diagnoses when cancer has spread from the original tumor site to other body tissues or organs. Gastroesophageal junction (GEJ) adenocarcinoma, a cancer originating at the junction where the esophagus meets the stomach, carries low five-year survival rates for me
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
246 
Let's personalize your content